These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Transfer of modified gut viromes improves symptoms associated with metabolic syndrome in obese male mice. Mao X; Larsen SB; Zachariassen LSF; Brunse A; Adamberg S; Mejia JLC; Larsen F; Adamberg K; Nielsen DS; Hansen AK; Hansen CHF; Rasmussen TS Nat Commun; 2024 Jun; 15(1):4704. PubMed ID: 38830845 [TBL] [Abstract][Full Text] [Related]
4. Faecal virome transplantation decreases symptoms of type 2 diabetes and obesity in a murine model. Rasmussen TS; Mentzel CMJ; Kot W; Castro-Mejía JL; Zuffa S; Swann JR; Hansen LH; Vogensen FK; Hansen AK; Nielsen DS Gut; 2020 Dec; 69(12):2122-2130. PubMed ID: 32165408 [TBL] [Abstract][Full Text] [Related]
5. Liu T; Song X; An Y; Wu X; Zhang W; Li J; Sun Y; Jin G; Liu X; Guo Z; Wang B; Lei P; Cao H Oxid Med Cell Longev; 2021; 2021():3328505. PubMed ID: 34804363 [TBL] [Abstract][Full Text] [Related]
6. Autochthonous faecal viral transfer (FVT) impacts the murine microbiome after antibiotic perturbation. Draper LA; Ryan FJ; Dalmasso M; Casey PG; McCann A; Velayudhan V; Ross RP; Hill C BMC Biol; 2020 Nov; 18(1):173. PubMed ID: 33218339 [TBL] [Abstract][Full Text] [Related]
7. Effects of fecal microbiota transplantation and fecal virome transplantation on LPS-induced intestinal injury in broilers. Wu D; Liang S; Du X; Xiao J; Feng H; Ren Z; Yang X; Yang X Poult Sci; 2024 Feb; 103(2):103316. PubMed ID: 38128454 [TBL] [Abstract][Full Text] [Related]
8. Novel Gut Microbiota Modulator, Which Markedly Increases Akkermansia muciniphila Occupancy, Ameliorates Experimental Colitis in Rats. Nakashima T; Fujii K; Seki T; Aoyama M; Azuma A; Kawasome H Dig Dis Sci; 2022 Jul; 67(7):2899-2911. PubMed ID: 34259969 [TBL] [Abstract][Full Text] [Related]
16. Influence of oral administration of Akkermansia muciniphila on the tissue distribution and gut microbiota composition of acute and chronic cadmium exposure mice. Feng S; Liu Y; Huang Y; Zhao J; Zhang H; Zhai Q; Chen W FEMS Microbiol Lett; 2019 Jul; 366(13):. PubMed ID: 31310663 [TBL] [Abstract][Full Text] [Related]
17. Oral Administration of miR-30d from Feces of MS Patients Suppresses MS-like Symptoms in Mice by Expanding Akkermansia muciniphila. Liu S; Rezende RM; Moreira TG; Tankou SK; Cox LM; Wu M; Song A; Dhang FH; Wei Z; Costamagna G; Weiner HL Cell Host Microbe; 2019 Dec; 26(6):779-794.e8. PubMed ID: 31784260 [TBL] [Abstract][Full Text] [Related]
18. A Critical Review on Akkermansia muciniphila: Functional Mechanisms, Technological Challenges, and Safety Issues. Abbasi A; Bazzaz S; Da Cruz AG; Khorshidian N; Saadat YR; Sabahi S; Ozma MA; Lahouty M; Aslani R; Mortazavian AM Probiotics Antimicrob Proteins; 2024 Aug; 16(4):1376-1398. PubMed ID: 37432597 [TBL] [Abstract][Full Text] [Related]
19. Infant behavioral state and stool microbiome in infants receiving Lactocaseibacillus rhamnosus GG in formula: randomized controlled trial. Shulman RJ; Chichlowski M; Orozco FG; Harris CL; Wampler JL; Bokulich NA; Berseth CL BMC Pediatr; 2022 Oct; 22(1):580. PubMed ID: 36207675 [TBL] [Abstract][Full Text] [Related]
20. Akkermansia muciniphila Prevents Fatty Liver Disease, Decreases Serum Triglycerides, and Maintains Gut Homeostasis. Kim S; Lee Y; Kim Y; Seo Y; Lee H; Ha J; Lee J; Choi Y; Oh H; Yoon Y Appl Environ Microbiol; 2020 Mar; 86(7):. PubMed ID: 31953338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]